Wanli Xing

Beijing VDJBio (China)

Papers

1

Total Citations

37

H-Index

1

About

Dr. Wanli Xing is a leading innovator in biomedical engineering and molecular diagnostics, with a focus on developing rapid, point-of-care technologies for infectious disease detection. His most impactful work centers on creating automated, portable laboratory systems that bring advanced diagnostic capabilities directly to the field. Notably, his 2021 paper on a highly automated mobile laboratory for on-site molecular diagnostics during the COVID-19 pandemic has garnered 37 citations, highlighting its critical role in pandemic response. This work addresses the urgent need for decentralized testing by integrating sample processing, nucleic acid amplification, and detection into a compact, user-friendly platform, significantly reducing turnaround times compared to traditional central laboratories. Dr. Xing’s contributions are pivotal in bridging the gap between laboratory-grade accuracy and field deployability, enabling rapid community screening and containment of outbreaks. His research not only advances public health infrastructure but also sets a new standard for agile diagnostic solutions in future global health emergencies, making him a key figure in the evolution of mobile health technologies.

Research Focus

Key Achievements

1
H-Index
1
Papers
37
Total Citations
37
Avg Citations/Paper
🏆 Most Cited Paper
A Highly Automated Mobile Laboratory for On-site Molecular Diagnostics in the COVID-19 Pandemic
37 citations · 2021
📈 Most Prolific Year: 2021 (1 Papers)
🤝 Key Collaborators: 22
🏛 Institutions: Beijing VDJBio (China)

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago